NKGEN Biotech

NKGN • NASDAQ

NKGEN Biotech is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul Y. Song, with a market cap of $21.6M.

CEOPaul Y. Song

Market Cap$21.6M

Biotechnology

Healthcare

Employees63.0

Next Earnings

Upcoming earnings announcement for NKGEN Biotech

Date

Tuesday, April 21, 2026 (in 1 week)

Timing

Before Market Open (6:00 AM New York)

Fiscal Period

Q3 2025

Past 7 earnings reports for NKGEN Biotech

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Jan 20, 2026	Q2 2025	-$0.04	—	-	—	10-Q
Oct 8, 2025	Q4 2024	-$0.95	—	-	—	10-K
Mar 4, 2025	Q3 2024	$0.15	—	-	—	10-Q
Sep 12, 2024	Q2 2024	-$0.67	—	-	—	10-Q
May 20, 2024	Q1 2024	-$0.25	—	-	—	10-Q
Apr 16, 2024	Q4 2023	-$1.68	—	-	—	10-K/A
Nov 14, 2023	Q3 2023	-$2.48	—	-	—	—